Key result
Patients with coronary slow flow had good long-term outcomes over a mean follow-up of 66 months, with low rates of cardiovascular death (2.5%) and myocardial infarction (1.5%).
Why the study?
What is the long-term prognosis of patients with coronary slow flow?
Cohort (n=213)
No
What is the long-term prognosis of patients with coronary slow flow?
Patients with coronary slow flow have a generally good long-term prognosis with low rates of myocardial infarction and cardiovascular death.
Supports reassuring CSF prognosis with low event rates; leaves open optimal follow-up strategies pending prospective validation.
Background: Coronary slow flow (CSF) is defined as decreased coronary blood circulation velocity and delayed opacification of contrast media during angiography. Evidence is insufficient regarding the course and prognosis of CSF patients. Long-term follow-up can help better understand the physiopathology and outcome of CSF. Accordingly, we assessed the long-term outcomes of CSF patients in this study. Methods: This retrospective cohort study was carried out on 213 CSF patients consecutively admitted to a tertiary health care center from April 2012 through March 2021. After data collection from the patients' files, follow-up was done via telephone call invitations and assessments of existing data in the outpatient cardiology clinic. The comparative analysis was conducted using a logistic regression test. Results: The mean follow-up length was 66.26±15.32 months, 105 patients (52.2%) were male, and the mean age of the patients was 53.81±11.91 years. The left anterior descending was the main affected artery (42.8%). At long-term follow-up, 19 patients (9.5%) required repeated angiography. Three patients (1.5%) had a myocardial infarction and 5 (2.5%) died from cardiovascular etiologies. Three patients (1.5%) underwent percutaneous coronary intervention. No patient required coronary artery bypass grafting. The need for a second angiography had no association with sex, symptoms, and echocardiographic findings. Conclusion: The long-term outcome of CSF patients is good, but their follow-up is necessary for the early diagnosis of cardiovascular-related adverse events.
No takes yet. Share an insight, caveat, or question.
Mikaeilvand et al. (2023) conducted a cohort in Coronary slow flow (n=213). Coronary slow flow was evaluated on Long-term cardiovascular outcomes (repeated angiography, myocardial infarction, cardiovascular death, percutaneous coronary intervention, coronary artery bypass grafting). Patients with coronary slow flow had good long-term outcomes over a mean follow-up of 66 months, with low rates of cardiovascular death (2.5%) and myocardial infarction (1.5%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: